LAPTOP (NEAT44) – The Late Presenter Treatment Optimisation Study  

An Open-Label, Multi-Centre, Randomised Study to Investigate Integrase Inhibitor Versus Boosted Protease Inhibitor Antiretroviral Therapy for Patients with Advanced HIV-Disease 

 

SPONSOR: NEAT ID Foundation 

 

Sponsor code: NEAT44 

EudraCT: 2018-003481-13 

 

Phase:  III

 

Indication:  ART-naïve HIV-1 infected patients

 

Countries: UK, France, Germany, Belgium, Spain, Italy, Ireland, Ukraine

 

Status:  Actively recruiting